Get started
Author

J. Rodríguez-Uranga

Observed names: J.J. Rodríguez-Uranga, Juan J. Rodriguez‐Uranga, Juan J. Rodríguez-Uranga, Juan J. Rodríguez‐Uranga, Juan Jesus Rodriguez‐Uranga, Juan Jesús Rodriguez-Uranga, Juan Jesús Rodríguez Uranga, Juan Jesús Rodríguez-Uranga, Juan Jesús Rodríguez‐Uranga, Juan Rodriguez-Uranga, Juan Rodriguez‐Uranga, Juan Rodríguez-Uranga, Juan Rodríguez‐Uranga
Observed institutions: Hospital Quirónsalud Sagrado Corazón, Sociedad Española de Medicina de Familia y Comunitaria, Hospital Regional Universitario de Málaga, Vall d'Hebron Hospital Universitari, Hospital Universitario Virgen del Rocío, Instituto de Investigación Biomédica de Málaga
ORCID: 0009-0007-5354-1256
Observed ORCID: 0009-0007-5354-1256
OpenAlex ID: A5066520183
Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: The FYDATA study
2016 · V. Villanueva, M. Garcés, et al. · Epilepsy Research · 129
Perampanel in routine clinical use in idiopathic generalized epilepsy: The 12‐month GENERAL study
2018 · Vicente Villanueva, Javier Montoya, et al. · Epilepsia · 111
PDF
Real‐world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program
2023 · Vicente Villanueva, Daniel Santos‐Carrasco, et al. · Epilepsia Open · 88
PDF
BRIVA-LIFE-A multicenter retrospective study of the long-term use of brivaracetam in clinical practice
2018 · Vicente Villanueva, Francisco Javier López-González, et al. · Acta Neurologica Scandinavica · 84
PDF
Long-term safety and efficacy of eslicarbazepine acetate in patients with focal seizures: Results of the 1-year ESLIBASE retrospective study
2014 · V. Villanueva, J.M. Serratosa, et al. · Epilepsy Research · 70
NEOPLASM study: Real-life use of lacosamide in patients with brain tumor-related epilepsy
2016 · Vicente Villanueva, Rosana Saiz-Diaz, et al. · Epilepsy & Behavior · 47
Euro-Esli: a European audit of real-world use of eslicarbazepine acetate as a treatment for partial-onset seizures
2017 · Vicente Villanueva, Martin Holtkamp, et al. · Journal of Neurology · 37
PDF
Early Add-on Lacosamide in a Real-Life Setting: Results of the REALLY Study
2014 · REALLY Study Group, Vicente Villanueva, et al. · Clinical Drug Investigation · 34
Treatment simplification to optimize cenobamate effectiveness and tolerability: A real‐world retrospective study in Spain
2024 · Juan Jesús Rodríguez‐Uranga, Juan María Sánchez‐Caro, et al. · Epilepsia Open · 30
Spanish consensus on the management of concomitant antiseizure medications when using cenobamate in adults with drug‐resistant focal seizures
2024 · Mar Carreño, Antonio Gil‐Nagel, et al. · Epilepsia Open · 27
Cenobamate and Clobazam Combination as Personalized Medicine in Autoimmune-Associated Epilepsy With Anti-Gad65 Antibodies
2023 · Pedro J. Serrano-Castro, Juan J. Rodríguez-Uranga, et al. · Neurology Neuroimmunology & Neuroinflammation · 27
PDF
Proposed Recommendations for the Management of Depression in Adults with Epilepsy: An Expert Consensus
2023 · Vicente Villanueva, Jesús Artal, et al. · Neurology and Therapy · 20
PDF
Perampanel outcomes at different stages of treatment in people with focal and generalized epilepsy treated in clinical practice: Evidence from the PERMIT study
2023 · Claudio Liguori, Estevo Santamarina, et al. · Frontiers in Neurology · 16
PDF
Efficacy and safety of eslicarbazepine-acetate in elderly patients with focal epilepsy: Case series
2017 · A. Gómez-Ibáñez, J.M. Serratosa, et al. · Seizure · 16
EARLY-ESLI study: Long-term experience with eslicarbazepine acetate after first monotherapy failure
2016 · V. Villanueva, P. Bermejo, et al. · Acta Neurologica Scandinavica · 16
EPICON consensus: Recommendations for proper management of switching to eslicarbazepine acetate in epilepsy
2017 · V. Villanueva, J. Ojeda, et al. · Neurología (English Edition) · 14
PDF
Consenso Delphi EPICON: recomendaciones sobre el manejo adecuado del cambio a acetato de eslicarbazepina en epilepsia
2016 · V. Villanueva, J. Ojeda, et al. · Neurología · 12
PDF
BRIVA‐ONE study: 12‐month outcomes of brivaracetam monotherapy in clinical practice
2024 · Vicente Villanueva, Esther González Villar, et al. · Epilepsia Open · 11
PDF
Impact of long‐term treatment with cenobamate on concomitant usage of antiseizure medications: A real‐world retrospective study in Spain
2025 · Juan María Sánchez‐Caro, Roshan Hariramani Ramchandani, et al. · Epilepsia · 5
PDF
Effectiveness and tolerability of fenfluramine in pediatric and adult patients with developmental and epileptic encephalopathies: A multicenter, retrospective, real‐world clinical‐practice study
2026 · Vicente Villanueva, Elena González‐Alguacil, et al. · Epilepsia · 2
Diagnóstico de trombosis venosas cerebrales mediante técnicas no invasivas
2006 · M.ªD. Moreno-Ramos, R. Rodríguez-Romero, et al. · Radiología · 2
Spanish translation, adaptation, and validation of the Epilepsy Surgery Satisfaction Questionnaire‐19
2025 · Elena Fonseca, Alejandro Thomson, et al. · Epilepsia · 1
Avances y orientaciones en el tratamiento de la epilepsia farmacorresistente: revisión de los nuevos fármacos cenobamato, fenfluramina y cannabidiol por la Sociedad Andaluza de Epilepsia
2024 · Carmen Arenas Cabrera, Pablo Cabezudo García, et al. · Revista de Neurología · 1
PDF
Erratum to “Safety, efficacy and outcome-related factors of perampanel over 12months in a real-world setting: The FYDATA study” [Epilepsy Res. 126 (2016) 201–210]
2016 · V. Villanueva, M. Garcés, et al. · Epilepsy Research · 1
Positioning Cenobamate in the Treatment Algorithm of Focal Epilepsy: Seizure Control and Benefits Beyond Seizures
2026 · Manuel Toledo, Vicente Villanueva, et al. · Neurology and Therapy
PDF
Works count: 26
Citation count: 801
H-index: 15
I10-index: 18
Year
Topic
Type